In the high-risk group, NK cells, dendritic cells, neutrophils, STAT family, MHC-I, and MHC-II were positively correlated with PAAD pathogenesis, and the immunotherapy target PDL-1 was also significantly different. Here, CD274 is linked to pancreatic adenocarcinoma.